CL2012001528A1 - Process to prepare the crystalline form a of ilaprazole from an inorganic salt of ilaprazole and subsequent neutralization of the salt with an acid in a reaction solvent; and process for preparing the crystalline form b of ilaprazole into the crystalline form a of ilaprazole. - Google Patents

Process to prepare the crystalline form a of ilaprazole from an inorganic salt of ilaprazole and subsequent neutralization of the salt with an acid in a reaction solvent; and process for preparing the crystalline form b of ilaprazole into the crystalline form a of ilaprazole.

Info

Publication number
CL2012001528A1
CL2012001528A1 CL2012001528A CL2012001528A CL2012001528A1 CL 2012001528 A1 CL2012001528 A1 CL 2012001528A1 CL 2012001528 A CL2012001528 A CL 2012001528A CL 2012001528 A CL2012001528 A CL 2012001528A CL 2012001528 A1 CL2012001528 A1 CL 2012001528A1
Authority
CL
Chile
Prior art keywords
ilaprazole
crystalline form
salt
prepare
acid
Prior art date
Application number
CL2012001528A
Other languages
Spanish (es)
Inventor
Dong Yeon Kim
Jae Soo Shin
Jun Yecun Lee
Kwi Hyung Cho
Sung Tae Park
Jung Woo Kim
Sang Don Nam
Hee Yun Kim
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Publication of CL2012001528A1 publication Critical patent/CL2012001528A1/en

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B30/00—Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images
    • G02B30/50—Optical systems or apparatus for producing three-dimensional [3D] effects, e.g. stereoscopic images the image being built up from image elements distributed over a 3D volume, e.g. voxels

Abstract

SE DIVULGAN UN PROCESO NOVEDOSO PARA PREPARAR LA FORMA CRISTALINA A ILAPRAZOL DE FÓRMULA 1. EL PROCESO NOVEDOSO INCLUYE UN PROCESO, PARA PREPARAR LA FORMA CRISTALINA A DE ALTA PUREZA MEDIANTE LA PREPARACIÓN DE UNA SAL INORGÁNICA DE ILAPRAZOL O UN HIDRATO DE LA MISMA Y LUEGO LA NEUTRALIZACIÓN DE LA SAL INORGÁNICA DE ILAPRAZOL PREPARADA O EL HIDRATO DE LA MISMA CON UN ÁCIDO EN UN SOLVENTE ORGÁNICO (SOLVENTE ÚNICO O SOLVENTE MIXTO); Y UN PROCESO DE CONVERSIÓN DE LA FORMA CRISTALINA B EN LA FORMA CRISTALINA A.<br />  A NOVEL PROCESS IS DISCLOSED TO PREPARE THE CRYSTALLINE FORM TO ILAPRAZOLE OF FORMULA 1. THE NOVEL PROCESS INCLUDES A PROCESS, TO PREPARE THE CRYSTALLINE FORM A OF HIGH PURITY THROUGH THE PREPARATION OF AN INORGANIC SALT OF THE MISIDRAZOLE OR ILAPRAZOLE NEUTRALIZATION OF PREPARED ILAPRAZOLE INORGANIC SALT OR THE HYDRATE OF THE SAME WITH AN ACID IN AN ORGANIC SOLVENT (SINGLE SOLVENT OR MIXED SOLVENT); AND A PROCESS OF CONVERSION FROM THE CRYSTAL FORM B INTO THE CRYSTAL FORM A. <br />

CL2012001528A 2009-01-02 2012-06-08 Process to prepare the crystalline form a of ilaprazole from an inorganic salt of ilaprazole and subsequent neutralization of the salt with an acid in a reaction solvent; and process for preparing the crystalline form b of ilaprazole into the crystalline form a of ilaprazole. CL2012001528A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090000121A KR100979113B1 (en) 2009-01-02 2009-01-02 Real Volumetric Display apparatus

Publications (1)

Publication Number Publication Date
CL2012001528A1 true CL2012001528A1 (en) 2012-11-30

Family

ID=42641428

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001528A CL2012001528A1 (en) 2009-01-02 2012-06-08 Process to prepare the crystalline form a of ilaprazole from an inorganic salt of ilaprazole and subsequent neutralization of the salt with an acid in a reaction solvent; and process for preparing the crystalline form b of ilaprazole into the crystalline form a of ilaprazole.

Country Status (2)

Country Link
KR (1) KR100979113B1 (en)
CL (1) CL2012001528A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102334400B1 (en) * 2021-03-18 2021-12-01 김봉준 A three-dimensional screen device having a lifting structure for each pixel and a control method thereof
KR102494740B1 (en) * 2021-03-18 2023-02-06 김봉준 A three-dimensional screen device having a lifting structure for each pixel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801666A (en) 1993-02-10 1998-09-01 Board Of Regents, The University Of Texas System Three-dimensional monitor
US5793918A (en) 1997-03-03 1998-08-11 Hogan; Richard J. Movable 3d display
US7196688B2 (en) * 2000-05-24 2007-03-27 Immersion Corporation Haptic devices using electroactive polymers
JP2003316299A (en) * 2002-04-23 2003-11-07 Nippon Hoso Kyokai <Nhk> Tactile sense display presentation device and configuration information encoding method

Also Published As

Publication number Publication date
KR100979113B1 (en) 2010-08-31
KR20100080710A (en) 2010-07-12

Similar Documents

Publication Publication Date Title
ES2660773T3 (en) Procedure for the preparation of a trialcaline-metallic crystalline salt of L-MGDA
CO6541539A2 (en) PROCESSES TO PREPARE THE CRYSTAL FORMS A AND B OF ILAPRAZOL AND PROCESS TO CONVERT THE CRYSTAL FORMS
AR098260A2 (en) CRYSTAL POLYMORPH OF A BISULFATE SALT OF AN ANTEGONIST OF THE THROMBIN RECEPTOR, PROCESS FOR PREPARATION, COMPOSITION AND PURIFIED FORM
CN103497762A (en) Method for synthesizing nitrogen doped carbon quantum dot based on one-step monocomponent hydro-thermal synthesis
MY167395A (en) Method for producing glufosinate p free acid
DK2057126T3 (en) Process for Preparation of 3-Dihalomethyl-Pyrazole-4-Carboxylic Acid Derivatives
WO2014128545A3 (en) An improved process for the preparation of dolutegravir
NZ601805A (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
MX2010009860A (en) Total synthesis of salinosporamide a and analogs thereof.
EA200900707A1 (en) A NEW METHOD OF SYNTHESIS OF 7,8-DIMETOXY-1,3-DIHYDRO-2H-3-BENZAZEPIN-2-SHE, AND ITS APPLICATION IN THE SYNTHESIS OF IVABRADIN AND ITS SALTS OF CONNECTION WITH PHARMACEUTICAL SUBSTITUTION
UA100125C2 (en) Method for isolation and purification of montelukast
AR109729A1 (en) METHOD FOR PRODUCING THE CRYSTAL FORM OF CALCOLUTROL MODIFICATION
RU2014143717A (en) HIGH PURITY CYCLOPEPTIDE CRYSTAL, AND ALSO THE WAY OF ITS PRODUCTION AND ITS APPLICATION
CL2012001528A1 (en) Process to prepare the crystalline form a of ilaprazole from an inorganic salt of ilaprazole and subsequent neutralization of the salt with an acid in a reaction solvent; and process for preparing the crystalline form b of ilaprazole into the crystalline form a of ilaprazole.
CL2012000270A1 (en) Preparation procedure of ivabradine and its addition salts by formation of the benzoacepine ring; and the intermediary compounds considered in the process.
MX2013004193A (en) Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives.
DK1940772T3 (en) New Process for Preparation of Quaternary Acid and Ammonium Salts
NZ598278A (en) Process for preparing biphenyl imidazole compounds
RU2010120061A (en) METHOD FOR PRODUCING SUBSTITUTED 4-NITRO-5- (2-OXOETHYL) PHTHALONITRILES
CN103130693A (en) Method for synthesizing bis-iso-propyl xanthogenat by using hydrogen peroxide
RU2014142545A (en) METHOD FOR PRODUCING 5- (DIFFORMETHYL) PYRAZINE-2-CARBOXYLIC ACID AND INTERMEDIATE COMPOUND WHEN ITS PREPARATION
UA102091C2 (en) Novel method for the production of sulphonylpyrroles as hdac inhibitors
NZ591756A (en) Processes for the synthesis of five and six membered heterocyclic rings
CN102382000A (en) Production method of D- para hydroxybenzene glycine
MX349425B (en) Novel process for synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)­pr opanenitrile, and application to the synthesis of ivabradine and of addition salts thereof with a pharmaceutically acceptable acid.